Hormone-dependent changes of blood vessels in DMBA-induced rat mammary carcinoma and its regression studied by 3H-thymidine autoradiography.
Using DMBA-induced rat breast cancer, the changes in the histology and proliferative activity underlying the phenomenon of tumor regression by hormone therapy were studied by 3H-thymidine autoradiography. The control tumor was found to essentially consist of two histologically different areas, medullary (A area) and tubular or cystic (B area). The cancer cells in the A area were homogeneously proliferating with a cell cycle time of 51h, and among those in the B area, 65% were proliferating with a cell cycle time of 81h while 35% were non-proliferating. Among the various-kinds of hormone therapies, ovariectomy plus male sex hormone administration was most effective in inducing tumor regression. In the regressed tumor, the A area was greatly diminished due to central necrosis and replaced by cystic B area. In the remaining A area, the cell cycle time was lengthened to 97h, and that for the proliferating cells in the B area was as long as 118h. The most striking histological change after ovariectomy plus male sex hormone administration was the diffuse necrosis of the capillary endothelial cell within 24h, followed by hemorrhage, central necrosis in the A area (1W), and final stage of fibrosis (2W). The tumor administered with female sex hormone after ovariectomy showed a rebound growth from the regression, due to the initial reactivation of the endothelial cell proliferation and following stimulation of cancer cell mitotic activity. From these observations, it is concluded that the capillary endothelial cells in DMBA-induced rat breast cancer are estrogen dependent, and that the tumor regression induced by decreased estrogen-level is attributable to the massive necrosis from capillary insufficiency and anoxia.
D015127:9,10-Dimethyl-1,2-benzanthracene; D000818:Animals; D001345:Autoradiography; D002196:Capillaries / Q000187:drug effects / Q000473:pathology; D002369:Castration; D004273:DNA, Neoplasm / Q000096:biosynthesis; D004727:Endothelium / Q000187:drug effects / Q000473:pathology; D004958:Estradiol / Q000627:therapeutic use*; D005260:Female; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000098:blood supply* / Q000139:chemically induced / Q000473:pathology / Q000503:physiopathology; D051381:Rats; D013739:Testosterone / Q000627:therapeutic use*; D013936:Thymidine / Q000378:metabolism
D004273:DNA, Neoplasm; D013739:Testosterone; D004958:Estradiol; D015127:9,10-Dimethyl-1,2-benzanthracene; D013936:Thymidine